Le Borse di oggi, 9 novembre. Il vaccino Pfizer fa volare i mercati dopo l'euforia per il successo di Biden. Balzo del petrolio - la Repubblica
Pfizer India unit shares up after global sale of nutrition business
PFE stock in focus amid concerns over outlook for COVID-related sales (NYSE:PFE) | Seeking Alpha
What to watch today: Wall Street set for another rally as Pfizer booster shows promise on omicron
Pfizer Inc. (PFE) Stock Price & News - Google Finance
PFE | Pfizer Inc. Stock Overview (U.S.: NYSE) | Barron's
Covid, i titoli di Borsa che salgono e scendono dopo l'annuncio del vaccino di Pfizer
Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine | PNAS
Wall Street Unleashes Fury at Pfizer's $1.5B Revenue Discrepancy - CBS News
Covid News: 35 Companies Sign on to Produce Generic Versions of Pfizer's Covid Pill - The New York Times
Wall St: S&P 500, Nasdaq slip as Pfizer, megacap stocks drag | Mint
Vaccinated, low-risk people won't benefit from COVID-19 pill Paxlovid: Pfizer study suggests - ABC News
Vaccine Stocks Drop After Pfizer's (PFE) Covid Sales-Forecast Miss - Bloomberg
Wall St extends record rally on strong jobs report, Pfizer COVID-19 pill cheer | Reuters
Pfizer vaccine, Israel expert: "First dose less effective of company data"
Pfizer's stock has not been removed from the NYSE | Ap | berkshireeagle.com
Buy Pfizer, Dump Salesforce? Exiles on Wall Street Are Worth a Look - WSJ
Pfizer: dal vaccino Covid ricavi per 15 miliardi e utile netto del 25-30% - Il Sole 24 ORE
Live news from December 17: Turkey suspends stock trading, France makes vaccination compulsory for restaurants and bars, New York reports record daily rise in Covid cases | Financial Times
Vaccinated, low-risk people won't benefit from COVID-19 pill Paxlovid: Pfizer study suggests - ABC News